Mindray Launches New Nerve Block Educational Series for Regional Anesthesia in Partnership with Dr. Richard Teames

The Series Aims to Enhance Patient Care and Clinical Outcomes by Providing Further Education for Anesthesiologists on POCUS

Mindray, a leading global developer of healthcare technologies and solutions specializing in patient monitoring, anesthesia, and ultrasound, has announced that it is partnering with renowned anesthesiologist and educator Richard Teames, MD, BSN, to release an educational video series on regional anesthesia and nerve blocks using its revolutionary TE X Ultrasound System.

Block Show video series
The Block Show video series offers tips and tricks for the upper extremity, thorax and abdomen, and lower extremity using ultrasound imaging over the course of several videos and downloadable best practice guides in partnership with Dr. Richard Teames.

Mindray notes this medical education series is aimed at the growing demand within the anesthesiology community to integrate ultrasound and AI technology at the bedside, demonstrating the company’s commitment to advancing ultrasound training and technology adoption.

The video series, “The Block Show with Dr. Teames,” will offer tips and tricks for the upper extremity, thorax and abdomen, and lower extremity using ultrasound imaging over the course of several videos and downloadable best practice guides. The series aims to address the growing demand for innovative point of care ultrasound (POCUS) technology in anesthesiology by educating clinicians on best practices and techniques with the TE X Ultrasound System.

The TE X Ultrasound System continues to redefine the limits of POCUS by further expanding its clinical use scenarios. Initially aimed at the Emergency Medicine (EM) and Critical Care markets, the TE X has made significant strides in the Anesthesia market. In response to this growing demand, Mindray has recently introduced a new version of its TE X Ultrasound System, the TE X Flex Procedural Edition. This innovative flexible solution is designed to address the diverse and evolving needs in ultrasound-guided regional anesthesia while offering anesthesiologists a powerful tool for performing nerve blocks and providing real-time guidance for vascular access, ultimately improving patient safety and outcomes.

“The TE-Series, particularly the TE X, has truly taken the POCUS community by storm,” said Jim Berry, Senior Marketing Manager for Point of Care Ultrasound at Mindray North America. “It is opening new doors, enabling novice users to quickly become proficient with imaging and AI tools, thereby enhancing both the quality and efficiency of patient care.”

The educational partnership underscores Dr. Teames’ and Mindray’s mutual commitment to providing clinicians with resources that elevate patient care and complement their clinical workflow. With over 20 years of experience in trauma and critical care environments, Dr. Teames has cultivated exceptional regional skills and ultrasound techniques in multiple nerve block modalities. He received anesthesia training as a resident at Memorial Hermann Healthcare System, one of the busiest level one trauma centers in the United States, serves as an anesthesiologist in the United States Army Reserve, and has held several other prestigious positions, including his current one as Director of Regional Anesthesia and National Clinical Director of Regional Anesthesia. Throughout his career, he has been enthusiastic about educating others about clinical anesthesia.

“The Block Show with Dr. Teames” is now available for viewing. The training videos can be accessed here: https://www.mindray.com/na/campaign/block-show/.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.